2,6-Dimethyl-3-nitropyridine

We are 2,6-Dimethyl-3-nitropyridine CAS:15513-52-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   2,6-Dimethyl-3-nitropyridine
CAS.NO:15513-52-7
Synonyms:    2,6-Dimethyl-3-nitropyridine
3-Nitro-2,6-dimethyl-pyridin
3-nitro-2,6-dimethylpyridine
2-methyl-5-nitro-6-methylpyridine
3-Nitro-2,6-lutidine
2,5-DIMETHOXY-4-CHLOROPHENETHYLAMINE HYDROCHLORIDE
 
Molecular Formula:C7H8N2O2
Molecular Weight:152.15100
 
Physical and Chemical Properties:
Density:1.45g/cm3
Boiling point:235.4ºC at 760 mmHg
Melting point:26-31 °C(lit.)
Flash point:100 °F
Index of Refraction:1.551
 
Specification:
Appearance:White Crystalline Powder
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates

2,6-Dimethyl-3-nitropyridine


Related News: Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.4-amino-1-metil-3-propil-1H-pirazol-5-carboxamida CAS:139756-02-8 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.4-Amino-3-(trifluoromethoxy)benzoic acid CAS:175278-22-5 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.2-bromo-4-cloropiridina CAS:22918-01-0 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
3-Fluoroanisole Cas:456-49-5 View Details
Chloromethyl Trimethoxysilane Cas:5926-26-1 View Details
Griseofulvin Cas:126-07-8 View Details
2-bromo-1-(3,5-difluorophenyl)ethanone manufacturer 3,5-Dibromo-4-hydroxybenzaldehyde manufacturer azulene Cas:275-51-4 manufacturer n,n-bis(2-hydroxyethyl)-p-phenylenediamine sulphate Cas:54381-16-7 manufacturer IBUPROFEN SODIUM SALT Cas:31121-93-4 manufacturer